←
Tim Shaw667 posts
Tim Shaw avatar

Tim Shaw

@gatechatl

Assistant Member/Professor, Bioinformatian & Cancer Researcher @ Moffitt. Interest in Immuno-oncology, ER stress, and alternative splicing. he/his

◷ Joined May 2012▧ 14 Photos and videos
Dr. Anthony Letai avatar
⟳ Tim Shaw retweeted
Dr. Anthony Letai@NCIDirector·Oct 20

If your Author Accepted Manuscript was supported by @NIH funding, it must be posted publicly to PMC without an embargo. There's no cost and it does not require buying expensive open access plans. Take steps to upload your Author Accepted Manuscript here: nihms.nih.gov/login/?next=/s…

.@JAMAInternalMed recently published a thoughtful piece on public access calling for NIH to assert its position regarding compliance with the NIH Public Access Policy. NIH has the right to make the Author Accepted Manuscript, which has been supported by taxpayers, public in PubMed Central at time of publication; a right which is independent from any publisher agreement. This is a free path to compliance for authors, helping us ensure rapid public access to NIH-supported research results.

Ed Reznik avatar
⟳ Tim Shaw retweeted
Ed Reznik@EdReznik·Sep 18

And if you're interesting in joining us in our adventure into toxicity, germline genetics, and precision safety, consider applying to this open postdoctoral position.

Post attachment

Incredibly excited to report today on the determinants of toxicity to systemic therapy in cancer patients. Led by many including Alex Guo, Feiyang Huang, Saksham Mohan, River Walser, and the fearless @ZiadBakouny. Co-led by Wes Tansey and Jian Carrot-Zhang medrxiv.org/content/10.64898…

Kosj Yamoah MD, PhD avatar
⟳ Tim Shaw retweeted
Kosj Yamoah MD, PhD@KOSJ12·Jul 17

Meeting the first patient who will receive proton therapy at @MoffittNews in just 10 days was a powerful reminder of why my work matters. Looking forward to beginning treatment and bringing this advanced technology closer to home for our community.

Post attachmentPost attachment
Ed Reznik avatar
⟳ Tim Shaw retweeted
Ed Reznik@EdReznik·Jun 15

Please RT: official post forthcoming, but for those currently hunting for postdocs, my group will have a fully funded position for an individual to lead our activities in computational analysis of radiographic data. If you have those skills and want to dream, please reach out.

GPTomics avatar
⟳ Tim Shaw retweeted
GPTomics@gptomics·May 27

@infoecho @domenjemec reviewed Conway's Law and the history of genome assemblers to see how including agents in academic labs will shape the research software ship. PIs will bifurcate further: either they'll ship more or end up even more removed. gptomics.com/blog/conway_law…

Dr. Jean Fan avatar
⟳ Tim Shaw retweeted
Dr. Jean Fan@JEFworks·May 30

As academic audit culture grows (now pre-approvals for conferences, foreign collabs, etc), I hope students will remember there's another way: academia built on mutual trust/obligation through collective effort My take on the neoliberal academic ecosystem: youtu.be/PGO4qgfm7DU

Post attachment
Tim Shaw avatar
Tim Shaw@gatechatl·May 12

Congrats Ada Lau (one of our ODYSSEY trainees) getting her research highlighted at the #MoffittScientificSymposium @MoffittNews

At #MoffittScientificSymposium, Ada Lau shares research investigating immunosuppressive features of the multiple myeloma tumor microenvironment following CAR-T therapy. Findings revealed CD8+ immune responses between complete response and progressive disease samples, highlighting interferon pathway activation in responders and TNF-alpha signaling in progressive disease.

1:19
Moffitt Cancer Center avatar
⟳ Tim Shaw retweeted
Moffitt Cancer Center@MoffittNews·May 11

At #MoffittScientificSymposium, Ada Lau shares research investigating immunosuppressive features of the multiple myeloma tumor microenvironment following CAR-T therapy. Findings revealed CD8+ immune responses between complete response and progressive disease samples, highlighting interferon pathway activation in responders and TNF-alpha signaling in progressive disease.

1:19